SUSQUEHANNA INTERNATIONAL GROUP, LLP - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$19,631,000
+567.0%
1,117,927
+268.5%
0.00%
Q2 2021$2,943,000
-42.7%
303,392
-36.5%
0.00%
Q1 2021$5,132,000
-80.6%
477,801
-73.5%
0.00%
-100.0%
Q4 2020$26,510,000
+200.2%
1,802,212
+190.0%
0.00%
+100.0%
Q3 2020$8,832,000
+143.5%
621,520
+38.6%
0.00%0.0%
Q2 2020$3,627,000
+352.2%
448,316
+125.8%
0.00%
Q1 2020$802,000
+1133.8%
198,586
+101.3%
0.00%
Q1 2019$65,000
-68.0%
98,673
+249.9%
0.00%
Q1 2018$203,000
-51.7%
28,200
-51.3%
0.00%
Q4 2017$420,000
+12.9%
57,900
+130.0%
0.00%
Q3 2016$372,00025,1700.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 701,138$4,067,0000.67%
Matrix Capital Management Company, LP 2,288,560$13,274,0000.33%
NEA Management Company, LLC 1,250,000$7,250,0000.31%
Stanley-Laman Group, Ltd. 139,403$809,0000.20%
Cormorant Asset Management, LP 500,000$2,900,0000.19%
Tekla Capital Management LLC 468,399$2,717,0000.10%
Wealth Alliance Advisory Group, LLC 21,800$126,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 175,339$1,007,0000.03%
Artal Group S.A. 150,000$870,0000.02%
Baker Brothers Advisors 505,262$2,931,0000.02%
View complete list of TRILLIUM THERAPEUTICS INC shareholders